Enhancing the Effectiveness of Androgen Deprivation in Prostate Cancer by Inducing Filamin a Nuclear Localization

Endocrine-Related Cancer - United Kingdom
doi 10.1530/erc-12-0171
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Risk of the "Androgen Deprivation Syndrome" in Men Receiving Androgen Deprivation for Prostate Cancer

Archives of Internal Medicine
2006English

Androgen Deprivation Therapy for Prostate Cancer

2017English

Evolving Use of Androgen Deprivation Therapy in Prostate Cancer Management

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2016English

Bisphenol a May Reduce the Efficacy of Androgen Deprivation Therapy in Prostate Cancer

Cancer Causes and Control
Cancer ResearchOncology
2009English

hASH1 Nuclear Localization Persists in Neuroendocrine Transdifferentiated Prostate Cancer Cells, Even Upon Reintroduction of Androgen

Scientific Reports
Multidisciplinary
2019English

Androgen Deprivation Therapy as Backbone Therapy in the Management of Prostate Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Use of Androgen Deprivation Therapy in Prostate Cancer: Indications and Prevalence

Asian Journal of Andrology
MedicineUrology
2012English

Androgen Deprivation Therapy for Prostate Cancer and Risk of Dementia

BJU International
Urology
2019English

Androgen Deprivation Therapy for Prostate Cancer—review of Indications in 2010

Current Oncology
Oncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy